Navidea Biopharmaceuticals, Inc. (NAVB)
Q4 2019 Results Earnings Conference Call
March 11, 2020, 5:00 pm ET
Company Participants
Jed Latkin - Chief Executive Officer, Chief Financial Officer, Chief Operating Officer
Mike Rosol - Chief Medical Officer
Erika Eves - Director Finance and Administration
Conference Call Participants
Mike Okunewitch - Maxim Group
Vernon Bernardino - H.C. Wainwright
Michael Liu - Private Investor
Mike Riccelli - Private Investor
Presentation
Jed Latkin
Thank you. Good afternoon and welcome, everyone, to Navidea's fourth quarter 2019 earnings call. I am Jed Latkin, Chief Executive Officer of Navidea Biopharmaceuticals. This call